Net Cash Provided by (Used in) Financing Activities of BioCorRx Inc. from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BioCorRx Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
  • BioCorRx Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $625,732, a 67% increase year-over-year.
  • BioCorRx Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1,119,065, a 40% decline from 2023.
  • BioCorRx Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,849,889, a 8.6% decline from 2022.
  • BioCorRx Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2,024,550, a 34% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BioCorRx Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $625,732 +$250,206 +67% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2024 Q1
Q1 2024 $375,526 -$156,901 -29% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2024 Q1
Q1 2023 $532,427 -$467,573 -47% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2022 $1,000,000 -$1,250,000 -56% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $2,250,000 +$2,250,000 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2020 $0 -$100,000 -100% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 $100,000 -$300,000 -75% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q1 2018 $400,000 -$2,027,252 -84% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q1 2017 $2,427,252 +$2,176,304 +867% 01 Jan 2017 31 Mar 2017 10-Q 18 May 2018 2018 Q1
Q1 2016 $250,948 +$106,367 +74% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q1 2015 $144,581 +$110,331 +322% 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016 2016 Q1
Q1 2014 $34,250 -$145,050 -81% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q1 2013 $179,300 +$146,996 +455% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q1 2012 $32,304 -$69,151 -68% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q1 2011 $101,455 01 Jan 2011 31 Mar 2011 10-Q 10 Jul 2012 2012 Q1

BioCorRx Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,119,065 -$730,824 -40% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $1,849,889 -$174,661 -8.6% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $2,024,550 -$1,056,890 -34% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $3,081,440 +$2,974,140 +2772% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $107,300 -$5,317,700 -98% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $5,425,000 +$3,275,000 +152% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $2,150,000 -$262,252 -11% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $2,412,252 +$162,216 +7.2% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019 2018 FY
2016 $2,250,036 +$2,130,955 +1790% 01 Jan 2016 31 Dec 2016 10-K 05 Apr 2018 2017 FY
2015 $119,081 +$309,305 01 Jan 2015 31 Dec 2015 10-K 13 Apr 2017 2016 FY
2014 $190,224 -$224,051 -662% 01 Jan 2014 31 Dec 2014 10-K 14 Apr 2016 2015 FY
2013 $33,827 -$974,096 -97% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
2012 $1,007,923 +$879,935 +688% 01 Jan 2012 31 Dec 2012 10-K 14 Apr 2014 2013 FY
2011 $127,988 +$13,229 +12% 01 Jan 2011 31 Dec 2011 10-K 15 Apr 2013 2012 FY
2010 $114,759 01 Jan 2010 31 Dec 2010 10-K 18 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.